Related references
Note: Only part of the references are listed.Rho-kinase inhibitor, fasudil, suppresses glioblastoma cell line progression in vitro and in vivo
Lin Deng et al.
CANCER BIOLOGY & THERAPY (2010)
Lentiviral shRNA screen of human kinases identifies PLK1 as a potential therapeutic target for osteosarcoma
Zhenfeng Duan et al.
CANCER LETTERS (2010)
The kinase Mirk is a potential therapeutic target in osteosarcoma
Cao Yang et al.
CARCINOGENESIS (2010)
Osteosarcoma Conventional treatment vs. gene therapy
Mei Lin Tan et al.
CANCER BIOLOGY & THERAPY (2009)
RhoE Inhibits 4E-BP1 Phosphorylation and eIF4E Function Impairing Cap-dependent Translation
Priam Villalonga et al.
JOURNAL OF BIOLOGICAL CHEMISTRY (2009)
Osteosarcoma
Patrick J. Messerschmitt et al.
JOURNAL OF THE AMERICAN ACADEMY OF ORTHOPAEDIC SURGEONS (2009)
Insulin-like growth factor-I receptor tyrosine kinase inhibitor cyclolignan picropodophyllin inhibits proliferation and induces apoptosis in multidrug resistant osteosarcoma cell lines
Zhenfeng Duan et al.
MOLECULAR CANCER THERAPEUTICS (2009)
PDK1 regulates cancer cell motility by antagonising inhibition of ROCK1 by RhoE
Sophie Pinner et al.
NATURE CELL BIOLOGY (2008)
Loss of mir-146a function in hormone-refractory prostate cancer
Shi-Lung Lin et al.
RNA (2008)
Anaplasma phagocytophilum specifically induces tyrosine phosphorylation of ROCK1 during infection
Venetta Thomas et al.
CELLULAR MICROBIOLOGY (2007)
Multiple drug resistance in osteogenic sarcoma: INT0133 from the Children's Oncology Group
Cindy L. Schwartz et al.
JOURNAL OF CLINICAL ONCOLOGY (2007)
Mirk/Dyrk1b mediates cell survival in rhabdomyosarcomas
Stephen E. Mercer et al.
CANCER RESEARCH (2006)
Osteosarcoma: Basic science and clinical implications
JB Hayden et al.
ORTHOPEDIC CLINICS OF NORTH AMERICA (2006)
Osteosarcoma relapse after combined modality therapy:: An analysis of unselected patients in the Cooperative Osteosarcoma Study Group (COSS)
B Kempf-Bielack et al.
JOURNAL OF CLINICAL ONCOLOGY (2005)
Prognostic factors in high-grade osteosarcoma of the extremities or trunk:: An analysis of 1,702 patients treated on neoadjuvant cooperative osteosarcoma study group protocols
SS Bielack et al.
JOURNAL OF CLINICAL ONCOLOGY (2002)
Share Paper
